Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7495 p358
29 March 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


NHS pharmacy workforce rises by 2 per cent between 2006 and 2007

The number of qualified pharmacy staff working in the NHS rose by nearly 2 per cent from September 2006 to September 2007, new figures show.

The latest workforce survey, published by the Department of Health, shows that the number of qualified pharmacy staff rose from 13,536 to 13,800 over this period (a rise of 1.95 per cent), equating to an increase in full-time equivalent staff from 11,902 to 12,139 (1.99 per cent). This is an increase on the year 2005–06 when pharmacy staff numbers were almost static, but follows an increasing trend, with numbers of pharmacy staff up by 30 per cent since 2001.

Pharmacy support staff have seen a massive expansion in number, with a 129 per cent increase between 1999 and 2007. However, there was a fall of 1.6 per cent during 2006–07 (from 3,322 to 3,268).

The latest figures show that of all qualified pharmacy staff working in the NHS, there are 10,776 full-time equivalents working in trusts, 1,355 working for primary care trusts, and just two working in strategic health authorities (seven people were classed as “other”).

David Miller, vice-president of the Guild of Healthcare Pharmacists, commented: “This lack of regional pharmaceutical presence is regrettable since local action on pharmacy issues will be more difficult and thus may require more central professional intervention. Without this intervention there may be missed opportunities for identification of workforce needs and associated planning based on denominators such as beds, population and patient activity.”

He continued: “For example, the Department of Health in England has given a clear commitment to increase the number of hospital preregistration graduates over the next few years to address the vacancy issue and, while we consider this is best addressed by a national recruitment and retention premium, this survey could at least allow those resources to be targeted more effectively.”

Back to Top


©The Pharmaceutical Journal